ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma

Oncology Learning Network

29/07/2022 7 min

BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma

Listen "BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma"

Descargar episodio

Episode Synopsis

Margherita Rimini, MD, discusses the potential link between BRCAness phenotype and response to platinum-based chemotherapy in cholangiocarcinoma.

More episodes of the podcast Oncology Learning Network

Navigating The Complexity of Melanoma Care: Part 6 21/05/2025

Navigating The Complexity of Melanoma Care: Part 5 21/05/2025

Navigating The Complexity of Melanoma Care: Part 4 21/05/2025

Navigating The Complexity of Melanoma Care: Part 3 21/05/2025

Navigating The Complexity of Melanoma Care: Part 2 21/05/2025

Navigating The Complexity of Melanoma Care: Part 1 21/05/2025

Community Education Program Improves Patient Education and Cancer Screening Rates 14/05/2025

Cholangioscopy: What Interventional Oncologists Need to Know Part 2 21/08/2024

Cholangioscopy: What Interventional Oncologists Need to Know 21/08/2024

Applications of AR in Interventional Oncology 20/06/2024

Ver todos los episodios